To download click here
CEO Cliff Holloway tells Proactive London why its antibody collaboration deal is significant and details how it complements Scancell's existing antibody technology. He also explains what is unique about Scancell's antibody pipeline.
The company is teaming up with an unnamed "major player" in the world of antibodies.
View all posts »